Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Patients With Plaque Psoriasis
Clinical trial NCT02274792 · COMPLETED
Trial details
- NCT number
- NCT02274792
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2015-11-01
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.